HK
Highly rated in
22
conditions
Highly rated in
22
conditions
Check Dr. Horacio C. Kaufmann's experience treating your condition:
About Dr. Horacio C. Kaufmann

Horacio Kaufmann is a Neurologist in New York, New York. Kaufmann has been practicing medicine for over 45 years and is highly rated in 22 conditions, according to our data. His top areas of expertise are Familial Dysautonomia, Orthostatic Hypotension, Hereditary Sensory and Autonomic Neuropathy Type 2, and Hajdu-Cheney Syndrome. He is licensed to treat patients in New York.

His clinical research consists of co-authoring 172 peer reviewed articles and participating in 20 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Horacio C. Kaufmann it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
Locations
462 1st Ave, New York, NY 10016
Other Locations
530 1st Ave, Suite 9q, New York, NY 10016
Background & Education
Graduate Institution
Other, 1978
Specialties
Neurology
Licenses
Psychiatry & Neurology in NY
Hospital Affiliations
Tisch Hospital
Penn Medicine Rittenhouse
CentraState Medical Center
NYC Health And Hospitals - Bellevue
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


18 Clinical Trials

Natural History Study of Synucleinopathies
Natural History of Familial Dysautonomia
Cutaneous Phosphorlyated α-synuclein Detection as a Biomarker of Synucleinopathy
A Phase 1b Clinical Trial of UB-312 in Patients With Synucleinopathies
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Phase 2 Norepinephrine Transporter Blockade, Autonomic Failure IND117394 12/28/12
Carbidopa in Familial Dysautonomia: Phase-II Study, Investigational New Drug (IND) 117435, Date: 01/07/13
The Nutritional Supplement Phosphatidylserine in Patients With Familial
Proprioception and Sensorimotor Control in Hereditary Sensory and Autonomic Neuropathy
A Single-Blind Placebo-Controlled Telemedicine Clinical Trial for Cognitive Behavioral Therapy in Familial Dysautonomia
The Safety and Tolerability of Kinetin, a Nutritional Supplement That Corrects the Splicing Defect, in Patients With Familial Dysautonomia
An Open-Label Pilot Trial of Cognitive Behavioral Therapy in Familial Dysautonomia
Carbidopa for the Treatment of Nausea and Vomiting in Familial Dysautonomia
A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
View 15 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors